prostate cancer

Latest Post

Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth Laurus Labs to Acquire 60% Stake in Canadian Biotech Firm Galenvs Sciences for $3.75 Million Fortis Healthcare Acquires Suguna Hospital in Bengaluru for ₹277 Crore Ro Launches Robin AI Health Agent to Personalise Medication and Patient Care Recommendations Laurus Labs Q2 Results: Net Profit Surges 126% to ₹441 Crore as Revenue Grows 33%

Camcevi China Approval 2026: 6-Month Prostate Drug

October 14, 2026 Simone Lamb

Camcevi China approval 2026: the NMPA clears a six-month leuprolide injection for advanced prostate cancer. A Chinese decision, not a new FDA one.

You missed

Bristol Myers Squibb Raises 2026 Revenue Forecast as Newer Drugs Drive Q3 Growth

October 30, 2026 Simone Lamb

Laurus Labs to Acquire 60% Stake in Canadian Biotech Firm Galenvs Sciences for $3.75 Million

October 30, 2026 Simone Lamb

Healthcare Services

Fortis Healthcare Acquires Suguna Hospital in Bengaluru for ₹277 Crore

October 30, 2026 Simone Lamb

Ro Launches Robin AI Health Agent to Personalise Medication and Patient Care Recommendations

October 30, 2026 Simone Lamb